Ronald Caponigro

Ronald Caponigro, CPA has a diverse work experience in various roles within the accounting field. Ronald began their career at Veris Consulting, Inc as a Senior Consultant from 2008 to 2011. Ronald then joined KPMG US as a Senior Associate from 2011 to 2013. Following that, they worked at FTI Consulting as Director, FLC - FAAS from 2013 to 2018. Ronald subsequently served as Assistant Controller at Sigilon Therapeutics, Inc. from 2018 to 2019. Ronald then joined Fusion Pharmaceuticals as Assistant Controller from 2019 to 2021. Currently, they hold the position of Executive Director, Corporate Controller at Dyne Therapeutics starting from 2023. Prior to that, they held the roles of Senior Director, Corporate Controller from 2022 to 2023 and Director of Accounting from 2021 to 2022 at the same company. Ronald Caponigro's extensive work experience showcases their expertise in the field of accounting and finance.

Ronald Caponigro, CPA pursued their education from 2004 to 2008 at James Madison University. During this time, they obtained a degree in Accounting. In July 2010, they further enhanced their qualifications by obtaining certification as a Certified Public Accountant from the Virginia Board of Accountancy.